检索

标题
作者
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A., Sharonova L., Burakshayev S., Kotelnikova E., Smirnova T.
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I., Aytbaev K., Yusupov F.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Fadeev V., Morgunova T.
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
Badalyan O., Savenkov A.
Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya
Ruyatkina L., Sorokin M.
Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii
Dibirov M., Gadzhimuradov R., Khalidov O., Kakubava M., Polyanskiy M.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.
TsENTRAL'NYY NESAKhARNYY DIABET: V ChEM SEKRET EFFEKTIVNOGO LEChENIYa?
Biryukova E.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E., Danilova T.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M., Biryukova E., Zilov A.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V., Nikitin V., Leval' P., Ermolova D., Molochnikov A., Ermolov A.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I., Demina A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
Is it possible to stop the diabetes epidemic?
Verbovoy A., Dolgikh Y., Verbovaya N.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
Features of urine microflora in diabetic patients
Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
Gusenbekova D., Ametov A., Butaeva S.
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
Arbatskaya N.
ISSLEDOVANIE SAVOR: OTKRYTIE NOVOY EPOKhI BEZOPASNOY FARMAKOTERAPII SAKhARNOGO DIABETA 2 TIPA
Yuryatin A.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A., Vorozhtsova E., Orlova T.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.
OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA
Biryukova E.
ROLE OF GLYCATION END-PRODUCTS BLOCKERS IN THE DEVELOPMENT OF NEUROLOGIC COMPLICATIONS OF DIABETES MELLITUS
Podachina S., Podachina S.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I., Romantsova T., Glinkina I., Romantsova T.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E., pl?midmagidsid Y.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.
Common bean (Phaseolus vulgaris L.)/
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.
New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus
Den'gin V., Dengin V.
Diabetic foot syndrome: approaches to treatment of infection
Privol'nev V., Privolnev V.
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
Pavlova M.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.
Disorders of the antidiuretic hormone secretion in infectious diseases of the central nervous system
Ermolenko K., Konev A., Ermolenko K.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.
Application of Cocarnit in complex treatment of patients with diabetic polyneuropathy in outpatient practice
Novikova L., Tarkhanova I., Dmitrieva O., Fomichev A., Kakaulina L.
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G., Antsiferov M., Alekseeva Y.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.
Therapy with nonsteroid antiinflammatory drugs in patients with acute nonspecific low back pain: dynamics of renal function: results of «PANDA» cogort study
Zolotovskaya I., Davydkin I., Borovkova N.
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
Biryukova E.
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM
Martynov A., Akatova E., Nikolin O., Urlaeva I.
Opyt primeneniya Aktovegina v lechenii neyroishemicheskoy formy sindroma «diabeticheskaya stopa»
Dibirov M., Gadzhimuradov R., Khalidov O., Proshin A., Kakubava M.
Kombinirovannaya terapiya bolevoy diabeticheskoy polineyropatii: rezul'taty pilotnogo issledovaniya
Khramilin V., Andreeva V., Demidova I.
SAKhARNYY DIABET: OT PONIMANIYa ETIOLOGII K VYBORU LEChENIYa
Kononenko I., Smirnova O.
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa
Antsiferov M.
GIPOGLIKEMII V PATOGENEZE SERDEChNO-SOSUDISTOGO RISKA
Ruyatkina L., Ruyatkin D., Berezovskaya G.
SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
Ametov A., Valitov B., Chernikova N., Antsiferov M.
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta?
Antsiferov M., Galstyan G.
Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
Ametov A., Valitov B., Chernikova N., Antsiferov M.
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY?
Antsiferov M., Ametov A., Zilov A., Antsiferov M., Ametov A., Zilov A.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T., Nikonova T.
EVALUATION OF THE CLINICAL AND ECONOMIC EFFICIENCY OF PHARMACOTHERAPY OF DIABETIC POLYNEUROPATHY
Matveev N., Matveev N.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
201 - 300 的 354 信息 << < 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##